Low ALT may serve as a quick and reliable surrogate marker for early identification of patients with AF who have sarcopenia and malnutrition and, consequently, a high risk of mortality and therefore need early intervention, including physical training and nutritional therapy. The gene discussed is GPT; the disease is sarcopenia.